genedrive (GDR) Share Price, News & Analysis

Company Overview

genedrive plc, a molecular diagnostics company, engages in developing and commercializing point of need diagnostics platform for infectious diseases, genotyping, pathogen detection, and other indications. The company provides Genedrive system, a rapid thermocycler and signal detection system and semi- automated system used forqualitative in vitro molecular diagnostic tests; and Genedrive CYP2C19 ID Kit, a point-of-care test for rapid CYP2C19 genotyping in time-critical emergency care settings. It also offers Genedrive MT-RNR1-ID Kit, a rapid genetic test in an emergency neonatal care setting; and tests for the detection of Antibiotic Induced Hearing Loss in neonates, confirmation of HCV infection prior to drug administration, pathogen detection of biological military threats and a point-of-care for COVID-19 detection system for use in areas, such as healthcare, workplace screening, travel requirements, and confirmation of antigen tests. It serves medical, biotechnology, and pharmaceutical industries in the United Kingdom, Europe, the United States, and internationally. The company was formerly known as Epistem Holdings Plc and changed its name to genedrive plc in July 2016. genedrive plc was founded in 2000 and is headquartered in Manchester, the United Kingdom.

Key Stats

• Today's Range: 2.35 to 2.49
• 50-Day Range: 1.79 to 2.93
• 52-Week Range: 1.41 to 12.30
• Volume: 2.07 million shs
• Average Volume: 13.78 million shs
• Market Capitalization: £12.99 million
• P/E Ratio: N/A
• Dividend Yield: 1.57%
• Price Target: N/A
• Consensus Rating: N/A

GDR Stock Analysis - Frequently Asked Questions

How have GDR shares performed this year?

genedrive's stock was trading at GBX 8.13 on January 1st, 2024. Since then, GDR shares have decreased by 70.6% and is now trading at GBX 2.39.
View the best growth stocks for 2024 here.

How were genedrive's earnings last quarter?

genedrive plc (LON:GDR) announced its quarterly earnings results on Tuesday, February, 4th. The company reported ($8.90) earnings per share for the quarter.

How do I buy shares of genedrive?

Shares of GDR stock and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What other stocks do shareholders of genedrive own?

Based on aggregate information from My MarketBeat watchlists, some other companies that genedrive investors own include Rolls-Royce Holdings plc (RR.L), B&M European Value Retail (BME), Coats Group (COA), 4D pharma (DDDD), Greencore Group (GNC), IQE (IQE) and Omega Diagnostics Group (ODX).

Company Calendar

• Last Earnings: 2/04/2020
• Today: 11/21/2024

Industry, Sector and Symbol

• Stock Exchange: LON
• Sector: Medical
• Industry: Diagnostics & Research
• Sub-Industry: N/A
• Current Symbol: LON:GDR
• Previous Symbol: LON:EHP
• CUSIP: N/A
• CIK: N/A
• Web: www.genedriveplc.com
• Phone: +44-161-9890245
• Fax: N/A
• Employees: 43
• Year Founded: N/A

Profitability

• EPS (Most Recent Fiscal Year): GBX (0.04)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: 0.01
• P/E Growth: N/A
• Net Income: £-5,000,000.00
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: -201.53%
• Return on Assets: -74.09%

Debt

• Debt-to-Equity Ratio: 8.57
• Current Ratio: 1.63
• Quick Ratio: 5.52

Sales & Book Value

• Annual Sales: £49,000.00
• Price / Sales: 271.57
• Cash Flow: GBX 1.23 per share
• Price / Cash Flow: 2.00
• Book Value: GBX 1 per share
• Price / Book: 2.45

Miscellaneous

• Outstanding Shares: 543,140,000
• Free Float: N/A
• Market Cap: £13.31 million
• Optionable: Not Optionable
• Beta: -0.04